Breast-specific gamma imaging demonstrates better specificity and sensitivity than mammography, ultrasound, and MRI, according to several studies presented at the RSNA meeting.
Breast-specific gamma imaging demonstrates better specificity and sensitivity than mammography, ultrasound, and MRI, according to several studies presented at the RSNA meeting.
Dr. Rachel Brem, director of breast imaging and intervention at George Washington University Medical Center, and colleagues conducted a retrospective multicenter study on 26 women with biopsy-proven invasive lobular carcinoma. BSGI had the greatest sensitivity at 93%. Mammography, ultrasound, and MRI had sensitivities of 79%, 68% and 83%, respectively. BSGI also detected an additional suspicious occult lesion in 29% of women.
Dr. Leora Lanzkowsky, former medical director of the Eisenhower Medical Center in Rancho Mirage, CA, and colleagues conducted BSGI and breast MRI on patients with complex, inconclusive mammographic and/or ultrasonic findings. The researchers examined 48 patients and found 63 abnormalities.
BSGI and MRI yielded consistent results in 37 of these areas and were inconsistent in 26. MRI was inconclusive in a greater number of benign cases: 10 versus three on BSGI. The sensitivities of BSGI and MRI were 96% and 88%, respectively, with specificities of 46% and 27%.
The gamma technique images breast cancer differently from MRI, mammography, or ultrasound. Instead of approaching breast cancer in an anatomic way, BSGI examines how breast cancer functions differently from surrounding tissue. Due to an increased rate of metabolic activity, cancerous cells in the breast absorb a greater amount of the pharmaceutical tracing agent injected into patients than does the normal surrounding tissue. In this way, BSGI can find occult lesions as small as 1 mm.
The radiation dose of BSGI is similar to that of mammography, according to Bob Moussa, president and CEO of Dilon Technologies, a manufacturer of a BSGI camera.
"Our BSGI imaging room is directly across from our reading room. We don't have any extra shielding. Patients can just leave and come into the general public. It's a very low dose of radiation," Brem said.
AI Facilitates Nearly 83 Percent Improvement in Turnaround Time for Fracture X-Rays
December 19th 2023In addition to offering a 98.5 percent sensitivity rate in diagnosing fractures on X-ray, an emerging artificial intelligence (AI) software reportedly helped reduce mean turnaround time on X-ray fracture diagnosis from 48 hours to 8.3 hours, according to new research presented at the Radiological Society of North America (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can an Emerging PET Radiotracer Enhance Detection of Prostate Cancer Recurrence?
December 14th 2023The use of 68Ga-RM2 PET/MRI demonstrated a 35 percent higher sensitivity rate than MRI alone for the diagnosis of biochemical recurrence of prostate cancer, according to research recently presented at the Radiological Society of North America (RSNA) conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Can AI Improve Detection of Extraprostatic Extension on MRI?
December 4th 2023Utilizing a deep learning-based AI algorithm to differentiate between diagnostic and non-diagnostic quality of prostate MRI facilitated a 10 percent higher specificity rate for diagnosing extraprostatic extension on multiparametric MRI, according to research presented at the recent RSNA conference.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.